Latest blog articles
-
An important part of becoming a fully-fledged academic is the development and curation of a research line. A research line is the main research topic and the thread throughout (large parts of) a career. It could be law and technology in private law, globalisation in public law, human rights in...
-
In Part I we explained the outstanding profile of the Facebook Whistleblower Frances Haugen. We now discuss the factors showing whether Haugen’s whistleblowing experience is an outlier or whether it is indicative of what we will be seeing in other whistleblower cases in the future.
-
“I don’t hate Facebook. I love Facebook. I want to save it”, wrote Frances Haugen as she resigned from Facebook and revealed tens of thousands of documents alleging Facebook has time and again prioritized profit over people.
-
There has been substantial political debate over the last decade about the role of experts in policymaking. But how are these trends likely to develop in future? Drawing on a new edited volume, Vigjilenca Abazi, Johan Adriaensen and Thomas Christiansen set out four distinct scenarios concerning the...
-
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
-
It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...
-
Most people’s gut-feeling would say yes… because it sounds unfair. The CJEU also opines yes, but bends EU trade mark protection rules considerably and thereby increases EU trade mark protection for trade mark proprietors regarding two aspects: 1) the scope of when a sign is used in the course of...
-
Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...
-
The biggest challenge of the 21st century is undoubtedly the question of how to tackle the effects of a rising population, expanding industrialisation and growing environmental degradation. Apart from an ever complex world, there are externalities that are the result of the way humankind has been...
-
Since “Champagne” is a protected designation of origin (PDO) under EU law, it is not self-evident whether a product that is not Champagne but which contains Champagne can use the protected term in its trade name.